Eli Lilly and Company (LLY) Balance Sheet: Assets & Liabilities

Eli Lilly and Company (LLY) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Eli Lilly and Company reported total assets of $112.48B and total liabilities of $85.94B. Shareholders' equity was $26.54B, up 85.9% from $14.27B a year earlier. Total debt stood at $42.50B against $7.27B in cash and short-term investments, a net debt position of $35.23B. That puts debt-to-equity at 1.60, compared with 2.36 a year earlier.

Eli Lilly and Company Balance Sheet Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Eli Lilly and Company (LLY) - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	7.27	3.27	2.82	2.07	3.82	3.66	2.34	7.32	6.54
Short-Term Investments	0.11	0.15	0.11	0.14	0.09	0.02	0.10	0.09	1.50
Cash & Short-Term Investments	7.27	3.27	3.04	2.44	3.91	3.68	2.44	7.41	8.03
Accounts Receivable	17.76	11.01	9.09	6.90	8.13	6.93	5.54	5.78	5.26
Inventory	13.74	7.59	5.77	4.31	3.89	3.98	3.19	3.10	4.46
Other Current Assets	14.46	8.61	5.69	2.95	2.53	2.87	2.54	4.27	1.45
Total Current Assets	55.63	32.74	25.73	18.03	18.45	17.46	13.71	20.55	19.20
Non-Current Assets
Property, Plant & Equipment (Net)	24.68	17.10	12.91	10.14	8.99	8.68	8.41	8.00	8.83
Long-Term Investments	2.80	3.22	3.05	2.90	3.21	2.97	1.96	2.02	5.68
Goodwill	5.90	5.77	4.94	4.07	3.89	3.77	3.68	1.37	4.37
Intangible Assets	6.52	6.17	6.91	7.21	7.69	7.45	6.62	1.07	4.03
Other Non-Current Assets	16.95	13.72	10.47	7.13	4.08	3.48	2.34	8.30	2.87
Total Non-Current Assets	56.85	45.98	38.28	31.46	30.35	29.17	25.58	23.36	25.78
Total Assets	112.48	78.72	64.01	49.49	48.81	46.63	39.29	43.91	44.98
Current Liabilities
Accounts Payable	5.38	3.23	2.60	1.93	1.67	1.61	1.41	1.21	1.41
Short-Term Debt	1.64	5.12	6.90	1.50	1.54	0.01	1.52	1.10	3.71
Current Portion of Long-Term Debt	1.64	0.78	0.75	0.00	1.54	-	-	-	-
Accrued Liabilities	2.38	2.09	1.65	1.06	0.96	-	-	-	-
Other Current Liabilities	25.84	17.94	16.14	12.65	11.72	10.37	8.69	9.19	8.89
Total Current Liabilities	35.23	28.38	27.29	17.14	15.05	12.48	11.78	11.89	14.54
Non-Current Liabilities
Long-Term Debt	40.87	28.53	18.32	14.74	15.35	16.59	14.30	9.20	9.93
Deferred Tax Liabilities	0.00	0.00	0.00	0.09	1.73	2.10	2.19	1.31	0.00
Other Non-Current Liabilities	9.85	7.54	7.53	6.84	7.52	9.64	8.32	10.60	8.85
Total Non-Current Liabilities	50.71	36.07	25.85	21.58	24.60	28.33	24.81	21.11	18.78
Total Liabilities	85.94	64.44	53.14	38.71	39.65	40.81	36.59	33.00	33.31
Stockholders' Equity
Common Stock	0.59	0.59	0.59	0.59	0.60	0.60	0.60	0.66	0.69
Retained Earnings	24.47	13.55	10.31	10.04	8.96	7.83	4.92	11.40	13.89
Accumulated Other Comprehensive Income	-5.87	-7.30	-7.34	-6.86	-4.34	-9.51	-9.54	-8.74	-8.73
Treasury Stock	-	0.05	0.04	0.05	-	-	-	-	-
Additional Paid-in Capital	7.35	7.44	7.25	3.86	3.77	6.72	6.62	6.51	2.73
Minority Interest	0.00	0.08	0.09	0.13	0.18	0.18	0.09	1.08	0.08
Shares Outstanding	0.89	0.90	0.90	0.95	-	-	-	-	-
Total Stockholders' Equity	26.54	14.27	10.86	10.78	8.98	5.64	2.61	9.83	11.59
Total Liabilities & Equity	112.48	78.72	64.01	49.49	48.81	46.63	39.29	43.91	44.98

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Eli Lilly and Company Balance Sheet

How much debt does Eli Lilly and Company have?

Eli Lilly and Company had total debt of $42.50B as of Dec 31, 2025, against $7.27B in cash and short-term investments. Its debt-to-equity ratio was 1.60. Total debt was $33.64B a year earlier.

What are Eli Lilly and Company's total assets?

Eli Lilly and Company reported total assets of $112.48B as of Dec 31, 2025, up 42.9% from $78.72B a year earlier. Total liabilities were $85.94B.

What is Eli Lilly and Company's shareholders' equity?

Eli Lilly and Company's shareholders' equity was $26.54B as of Dec 31, 2025, or about $29.65 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition